Do analysts prefer AVNS or SNAL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Snail 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is AVNS or SNAL more profitable?

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Snail -11.73% -15.49% 5.24%

Does the media favor AVNS or SNAL?

In the previous week, Snail had 6 more articles in the media than Avanos Medical. MarketBeat recorded 7 mentions for Snail and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.80 beat Snail's score of 0.62 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Snail 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AVNS or LIVN?

LivaNova has a consensus price target of $79.38, suggesting a potential upside of 9.69%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LivaNova 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.67

Does the media favor AVNS or LIVN?

In the previous week, LivaNova had 2 more articles in the media than Avanos Medical. MarketBeat recorded 3 mentions for LivaNova and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.80 beat LivaNova's score of 0.09 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AVNS or NVST?

Envista has a consensus price target of $28.83, indicating a potential upside of 24.94%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Envista 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better earnings & valuation, AVNS or NVST?

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $701.20M 1.67 -$72.90M -$1.61 N/A Envista $2.72B 1.38 $47M $0.41 56.29

Do analysts rate IRTC or AVNS?

iRhythm Technologies currently has a consensus target price of $189.69, suggesting a potential upside of 75.46%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 1 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 2.94 Avanos Medical 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor IRTC or AVNS?

In the previous week, iRhythm Technologies had 3 more articles in the media than Avanos Medical. MarketBeat recorded 4 mentions for iRhythm Technologies and 1 mentions for Avanos Medical. iRhythm Technologies' average media sentiment score of 1.24 beat Avanos Medical's score of 0.80 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer MMED or AVNS?

MiniMed Group presently has a consensus target price of $21.33, indicating a potential upside of 49.92%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities analysts plainly believe MiniMed Group is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiniMed Group 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.73 Avanos Medical 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, MMED or AVNS?

MiniMed Group has higher revenue and earnings than Avanos Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $2.99B 1.34 N/A N/A N/A Avanos Medical $701.20M 1.67 -$72.90M -$1.61 N/A

Does the media refer more to MMED or AVNS?

In the previous week, MiniMed Group had 8 more articles in the media than Avanos Medical. MarketBeat recorded 9 mentions for MiniMed Group and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.80 beat MiniMed Group's score of -0.23 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Avanos Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Avanos Medical (AVNS) Competitors

$25.06 +0.06 (+0.26%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$25.04 -0.03 (-0.12%)

As of 06/5/2026 04:49 PM Eastern

Compare

AVNS vs. SNAL, LIVN, NVST, IRTC, and MMED

Should you buy Avanos Medical stock or one of its competitors? MarketBeat compares Avanos Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avanos Medical include Snail (SNAL), LivaNova (LIVN), Envista (NVST), iRhythm Technologies (IRTC), and MiniMed Group (MMED).

How does Avanos Medical compare to Snail?

Avanos Medical (NYSE:AVNS) and Snail (NASDAQ:SNAL) are related small-cap companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Avanos Medical has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market. Comparatively, Snail has a beta of 1.31, indicating that its share price is 31% more volatile than the broader market.

In the previous week, Snail had 6 more articles in the media than Avanos Medical. MarketBeat recorded 7 mentions for Snail and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.80 beat Snail's score of 0.62 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Snail	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Snail has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
Snail	$81.23M	0.35	-$27.24M	-$0.62	N/A

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Snail	-11.73%	-15.49%	5.24%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Snail	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 0.4% of Snail shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by company insiders. Comparatively, 68.3% of Snail shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Snail beats Avanos Medical on 8 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to LivaNova?

Avanos Medical (NYSE:AVNS) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

In the previous week, LivaNova had 2 more articles in the media than Avanos Medical. MarketBeat recorded 3 mentions for LivaNova and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.80 beat LivaNova's score of 0.09 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LivaNova	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LivaNova has a consensus price target of $79.38, suggesting a potential upside of 9.69%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LivaNova	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

LivaNova has a net margin of 7.48% compared to Avanos Medical's net margin of -10.39%. LivaNova's return on equity of 16.48% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
LivaNova	7.48%	16.48%	7.59%

Avanos Medical has higher earnings, but lower revenue than LivaNova. Avanos Medical is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
LivaNova	$1.39B	2.86	-$242.47M	$1.95	37.11

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Avanos Medical has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

Summary

LivaNova beats Avanos Medical on 12 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Avanos Medical (NYSE:AVNS) and Envista (NYSE:NVST) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

In the previous week, Avanos Medical had 1 more articles in the media than Envista. MarketBeat recorded 1 mentions for Avanos Medical and 0 mentions for Envista. Avanos Medical's average media sentiment score of 0.80 beat Envista's score of 0.50 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Avanos Medical	Positive
Envista	Positive

Envista has a consensus price target of $28.83, indicating a potential upside of 24.94%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Avanos Medical has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market. Comparatively, Envista has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

Envista has a net margin of 2.41% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.11% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Envista	2.41%	7.11%	3.91%

95.2% of Avanos Medical shares are held by institutional investors. 2.3% of Avanos Medical shares are held by company insiders. Comparatively, 1.0% of Envista shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
Envista	$2.72B	1.38	$47M	$0.41	56.29

Summary

Envista beats Avanos Medical on 9 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Avanos Medical (NYSE:AVNS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

iRhythm Technologies currently has a consensus target price of $189.69, suggesting a potential upside of 75.46%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

iRhythm Technologies has a net margin of -3.53% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Avanos Medical	-10.39%	5.39%	3.97%

iRhythm Technologies has higher revenue and earnings than Avanos Medical. iRhythm Technologies is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.75	-$44.55M	-$0.86	N/A
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A

iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.56, indicating that its stock price is 56% more volatile than the broader market.

95.2% of Avanos Medical shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by company insiders. Comparatively, 2.3% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, iRhythm Technologies had 3 more articles in the media than Avanos Medical. MarketBeat recorded 4 mentions for iRhythm Technologies and 1 mentions for Avanos Medical. iRhythm Technologies' average media sentiment score of 1.24 beat Avanos Medical's score of 0.80 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

iRhythm Technologies beats Avanos Medical on 11 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Avanos Medical (NYSE:AVNS) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

MiniMed Group presently has a consensus target price of $21.33, indicating a potential upside of 49.92%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities analysts plainly believe MiniMed Group is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73
Avanos Medical	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, MiniMed Group had 8 more articles in the media than Avanos Medical. MarketBeat recorded 9 mentions for MiniMed Group and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.80 beat MiniMed Group's score of -0.23 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avanos Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiniMed Group has higher revenue and earnings than Avanos Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A

19.7% of MiniMed Group shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 2.2% of MiniMed Group shares are owned by insiders. Comparatively, 2.3% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

MiniMed Group has a net margin of 0.00% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Avanos Medical	-10.39%	5.39%	3.97%

Summary

MiniMed Group and Avanos Medical tied by winning 6 of the 12 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$1.17B	$7.25B	$6.66B	$23.06B
Dividend Yield	N/A	1.20%	2.67%	4.10%
P/E Ratio	-15.57	45.87	24.03	30.25
Price / Sales	1.67	44.67	518.10	22.07
Price / Cash	7.31	25.19	26.99	18.46
Price / Book	1.50	6.95	10.24	4.62
Net Income	-$72.90M	$159.22M	$3.57B	$1.07B
7 Day Performance	1.01%	-2.59%	-1.28%	-1.66%
1 Month Performance	1.17%	1.84%	1.38%	-1.07%
1 Year Performance	101.64%	-1.02%	23.93%	21.20%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	1.0292 of 5 stars	$25.06 +0.3%	N/A	+101.6%	$1.17B	$701.20M	N/A	2,287	News Coverage
SNAL Snail	1.5246 of 5 stars	$0.84 -6.7%	N/A	-24.3%	$34.17M	$81.23M	N/A	60	News Coverage
LIVN LivaNova	2.7106 of 5 stars	$72.75 -1.4%	$79.38 +9.1%	+57.5%	$4.05B	$1.43B	37.85	3,300
NVST Envista	3.7485 of 5 stars	$23.30 -1.1%	$28.83 +23.8%	+22.9%	$3.80B	$2.81B	56.93	12,000
IRTC iRhythm Technologies	4.2886 of 5 stars	$107.44 -5.7%	$189.69 +76.5%	-26.3%	$3.74B	$787.85M	N/A	2,400	News Coverage Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 6/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LIVN, NVST, IRTC, and MMED

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to LivaNova?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Summary

How does Avanos Medical compare to MiniMed Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LIVN, NVST, IRTC, and MMED

How does Avanos Medical compare to Snail?

Which has more risk and volatility, AVNS or SNAL?

Does the media favor AVNS or SNAL?

Which has preferable earnings & valuation, AVNS or SNAL?

Is AVNS or SNAL more profitable?

Do analysts prefer AVNS or SNAL?

Do insiders & institutionals believe in AVNS or SNAL?

Summary

How does Avanos Medical compare to LivaNova?

Does the media favor AVNS or LIVN?

Do analysts recommend AVNS or LIVN?

Is AVNS or LIVN more profitable?

Which has better valuation and earnings, AVNS or LIVN?

Do insiders & institutionals have more ownership in AVNS or LIVN?

Which has more risk & volatility, AVNS or LIVN?

Summary

How does Avanos Medical compare to Envista?

Does the media prefer AVNS or NVST?

Do analysts recommend AVNS or NVST?

Which has more volatility and risk, AVNS or NVST?

Is AVNS or NVST more profitable?

Do insiders & institutionals believe in AVNS or NVST?

Which has better earnings & valuation, AVNS or NVST?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Do analysts rate IRTC or AVNS?

Is IRTC or AVNS more profitable?

Which has better valuation and earnings, IRTC or AVNS?

Which has more risk & volatility, IRTC or AVNS?

Do institutionals & insiders hold more shares of IRTC or AVNS?

Does the media favor IRTC or AVNS?

Summary

How does Avanos Medical compare to MiniMed Group?

Do analysts prefer MMED or AVNS?

Does the media refer more to MMED or AVNS?

Which has preferable valuation and earnings, MMED or AVNS?

Do institutionals and insiders believe in MMED or AVNS?

Is MMED or AVNS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools